What determines the optimal pharmacological treatment of atrial fibrillation? Insights from in silico trials in 800 virtual atria
The best pharmacological treatment for each atrial fibrillation (AF) patient is unclear. We aim to exploit AF simulations in 800 virtual atria to identify key patient characteristics that guide the optimal selection of anti-arrhythmic drugs. The virtual cohort considered variability in electrophysio...
Saved in:
| Published in: | The Journal of physiology Vol. 601; no. 18; pp. 4013 - 4032 |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Wiley Subscription Services, Inc
01.09.2023
John Wiley and Sons Inc |
| Subjects: | |
| ISSN: | 0022-3751, 1469-7793, 1469-7793 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | The best pharmacological treatment for each atrial fibrillation (AF) patient is unclear. We aim to exploit AF simulations in 800 virtual atria to identify key patient characteristics that guide the optimal selection of anti-arrhythmic drugs. The virtual cohort considered variability in electrophysiology and low voltage areas (LVA) and was developed and validated against experimental and clinical data from ionic currents to ECG. AF sustained in 494 (62%) atria, with large inward rectifier K
current (I
) and Na
/K
pump (I
) densities (I
0.11 ± 0.03 vs. 0.07 ± 0.03 S mF
; I
0.68 ± 0.15 vs. 0.38 ± 26 S mF
; sustained vs. un-sustained AF). In severely remodelled left atrium, with LVA extensions of more than 40% in the posterior wall, higher I
(median density 0.12 ± 0.02 S mF
) was required for AF maintenance, and rotors localized in healthy right atrium. For lower LVA extensions, rotors could also anchor to LVA, in atria presenting short refractoriness (median L-type Ca
current, I
, density 0.08 ± 0.03 S mF
). This atrial refractoriness, modulated by I
and fast Na
current (I
), determined pharmacological treatment success for both small and large LVA. Vernakalant was effective in atria presenting long refractoriness (median I
density 0.13 ± 0.05 S mF
). For short refractoriness, atria with high I
(median density 8.92 ± 2.59 S mF
) responded more favourably to amiodarone than flecainide, and the opposite was found in atria with low I
(median density 5.33 ± 1.41 S mF
). In silico drug trials in 800 human atria identify inward currents as critical for optimal stratification of AF patient to pharmacological treatment and, together with the left atrial LVA extension, for accurately phenotyping AF dynamics. KEY POINTS: Atrial fibrillation (AF) maintenance is facilitated by small L-type Ca
current (I
) and large inward rectifier K
current (I
) and Na
/K
pump. In severely remodelled left atrium, with low voltage areas (LVA) covering more than 40% of the posterior wall, sustained AF requires higher I
and rotors localize in healthy right atrium. For lower LVA extensions, rotors can also anchor to LVA, if the atria present short refractoriness (low I
) Vernakalant is effective in atria presenting long refractoriness (high I
). For short refractoriness, atria with fast Na
current (I
) up-regulation respond more favourably to amiodarone than flecainide, and the opposite is found in atria with low I
. The inward currents (I
and I
) are critical for optimal stratification of AF patient to pharmacological treatment and, together with the left atrial LVA extension, for accurately phenotyping AF dynamics. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Handling Editors: Harold Schultz & Eleonora Grandi The peer review history is available in the Supporting Information section of this article (https://doi.org/10.1113/JP284730#support‐information‐section). |
| ISSN: | 0022-3751 1469-7793 1469-7793 |
| DOI: | 10.1113/JP284730 |